News
At the halfway mark last year, 97 layoff rounds were reported, marking a 32% year-over-year increase for the first half of ...
Zura Bio (NASDAQ:ZURA) has announced the appointment of Eric Hyllengren as CFO, effective July 7, 2025. He will succeed Verender Badial, who will step down from the role and remain with the company as ...
Zura Bio Limited (Nasdaq: ZURA) ("Zura Bio"), a clinical-stage, multi-asset immunology company developing novel dual-pathway ...
Hydroxychloroquine is tied to reduced preeclampsia risk but not preterm birth risk in pregnant patients with lupus in a ...
The latest research study released by Coherent Market Insights on "Immune Cell Therapy Market 2025 Forecast to 2032" research provides accurate economic, global, and country-level predictions and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results